Tumoroid à la carte: Path for personalization

Kyle Lewis¹, Takanori Takebe^{1

2

3

4}

Affiliations

¹ Division of Gastroenterology, Hepatology & Nutrition Developmental Biology Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
² Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
³ Advanced Medical Research Center, Yokohama City University, Yokohama, Kanagawa, Japan.
⁴ Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.

Comment

Kyle Lewis et al. Hepatology. 2018 Sep.

. 2018 Sep;68(3):1189-1191.

doi: 10.1002/hep.29846. Epub 2018 May 14.

Kyle Lewis¹, Takanori Takebe^{1

2

3

4}

¹ Division of Gastroenterology, Hepatology & Nutrition Developmental Biology Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
² Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
³ Advanced Medical Research Center, Yokohama City University, Yokohama, Kanagawa, Japan.
⁴ Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.

No abstract available

Comment on

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, Georgakopoulos N, Koo BK, Dietmann S, Davies SE, Praseedom RK, Lieshout R, IJzermans JNM, Wigmore SJ, Saeb-Parsy K, Garnett MJ, van der Laan LJ, Huch M. Broutier L, et al. Nat Med. 2017 Dec;23(12):1424-1435. doi: 10.1038/nm.4438. Epub 2017 Nov 13. Nat Med. 2017. PMID: 29131160 Free PMC article.